ZNF367 Inhibits Cancer Progression and is Targeted by MiR-195

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Jul 23

PMID 25047265

Citations 24

Authors

Meenu Jain

Lisa Zhang

Myriem Boufraqech

Yi Liu-Chittenden

Kimberly Bussey

Michael J Demeure

Xiaolin Wu

Ling Su

Karel Pacak

Constantine A Stratakis

Electron Kebebew

Affiliations

Soon will be listed here.

Abstract

Background: Several members of the zinc finger protein family have been recently shown to have a role in cancer initiation and progression. Zinc finger protein 367 (ZNF367) is a member of the zinc finger protein family and is expressed in embryonic or fetal erythroid tissue but is absent in normal adult tissue.

Methodology/principal Findings: We show that ZNF367 is overexpressed in adrenocortical carcinoma, malignant pheochromocytoma/paraganglioma and thyroid cancer as compared to normal tissue and benign tumors. Using both functional knockdown and ectopic overexpression in multiple cell lines, we show that ZNF367 inhibits cellular proliferation, invasion, migration, and adhesion to extracellular proteins in vitro and in vivo. Integrated gene and microRNA expression analyses showed an inverse correlation between ZNF367 and miR-195 expression. Luciferase assays demonstrated that miR-195 directly regulates ZNF367 expression and that miR-195 regulates cellular invasion. Moreover, integrin alpha 3 (ITGA3) expression was regulated by ZNF367.

Conclusions/significance: Our findings taken together suggest that ZNF367 regulates cancer progression.

Citing Articles

Exploring the Role of SMPD3 in the lncRNA-miRNA-mRNA Regulatory Network in TBI Progression by Influencing Energy Metabolism.

Cui C, Xu B, Liu H, Wang C, Zhang T, Jiang P J Inflamm Res. 2024; 17:10835-10848.

PMID: 39677286 PMC: 11646434. DOI: 10.2147/JIR.S491290.

Modulation of Epithelial-Mesenchymal Transition Is a Possible Underlying Mechanism for Inducing Chemoresistance in MIA PaCa-2 Cells against Gemcitabine and Paclitaxel.

Nakamura H, Watanabe M, Takada K, Sato T, Hikage F, Umetsu A Biomedicines. 2024; 12(5).

PMID: 38790973 PMC: 11118094. DOI: 10.3390/biomedicines12051011.

Research progress and perspectives of noncoding RNAs in adrenocortical carcinoma: A review.

Xu C, Xu P, Zhang J, He S, Hua T, Huang A Medicine (Baltimore). 2024; 103(4):e36908.

PMID: 38277554 PMC: 10817030. DOI: 10.1097/MD.0000000000036908.

Advances in translational research of the rare cancer type adrenocortical carcinoma.

Ghosh C, Hu J, Kebebew E Nat Rev Cancer. 2023; 23(12):805-824.

PMID: 37857840 DOI: 10.1038/s41568-023-00623-0.

Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment.

Dai Y, Zhang X, Ou Y, Zou L, Zhang D, Yang Q Cell Commun Signal. 2023; 21(1):190.

PMID: 37537585 PMC: 10399053. DOI: 10.1186/s12964-023-01183-4.

References

Duan Z, Choy E, Harmon D, Yang C, Ryu K, Schwab J . ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines. PLoS One. 2009; 4(9):e6967. PMC: 2734182. DOI: 10.1371/journal.pone.0006967. View

Seyhan A, Varadarajan U, Choe S, Liu W, Ryan T . A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers. Mol Biosyst. 2012; 8(5):1553-70. DOI: 10.1039/c2mb05512k. View

Slaby O, Redova M, Poprach A, Nekvindova J, Iliev R, Radova L . Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer. 2012; 51(7):707-16. DOI: 10.1002/gcc.21957. View

Hua Mao J, Zhou R, Peng A, Liu Z, Huang S, Long X . microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. Oncol Lett. 2012; 4(5):1125-1129. PMC: 3499598. DOI: 10.3892/ol.2012.863. View

Xing M, Alzahrani A, Carson K, Viola D, Elisei R, Bendlova B . Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA. 2013; 309(14):1493-501. PMC: 3791140. DOI: 10.1001/jama.2013.3190. View

Bai Y, Yang W, Yang H, Liao Q, Ye G, Fu G . Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression. PLoS One. 2012; 7(6):e38875. PMC: 3378540. DOI: 10.1371/journal.pone.0038875. View

Kuramoto K, Uesaka T, Kimura A, Kobayashi M, Watanabe H, Katoh O . ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells. Cancer Res. 2000; 60(2):425-30. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Wang T, Wang X, Xu J, Wu X, Qiu H, Yi H . Overexpression of the human ZNF300 gene enhances growth and metastasis of cancer cells through activating NF-kB pathway. J Cell Mol Med. 2011; 16(5):1134-45. PMC: 4365892. DOI: 10.1111/j.1582-4934.2011.01388.x. View

10.

Pasini B, Stratakis C . SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med. 2009; 266(1):19-42. PMC: 3163304. DOI: 10.1111/j.1365-2796.2009.02111.x. View

11.

Asano H, Murate T, Naoe T, Saito H, Stamatoyannopoulos G . Molecular cloning and characterization of ZFF29: a protein containing a unique Cys2His2 zinc-finger motif. Biochem J. 2004; 384(Pt 3):647-53. PMC: 1134151. DOI: 10.1042/BJ20040394. View

12.

Rossi M, Abbondanza C, DArcangelo A, Gazzerro P, Medici N, Moncharmont B . The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation. Cancer Lett. 2004; 215(2):229-37. DOI: 10.1016/j.canlet.2004.05.014. View

13.

Sachs N, Secades P, van Hulst L, Kreft M, Song J, Sonnenberg A . Loss of integrin α3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells. Proc Natl Acad Sci U S A. 2012; 109(52):21468-73. PMC: 3535625. DOI: 10.1073/pnas.1204614110. View

14.

Soon P, Tacon L, Gill A, Bambach C, Sywak M, Campbell P . miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. Clin Cancer Res. 2009; 15(24):7684-7692. DOI: 10.1158/1078-0432.CCR-09-1587. View

15.

Furuta M, Kozaki K, Tanimoto K, Tanaka S, Arii S, Shimamura T . The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PLoS One. 2013; 8(3):e60155. PMC: 3609788. DOI: 10.1371/journal.pone.0060155. View

16.

Finnerty J, Wang W, Hebert S, Wilfred B, Mao G, Nelson P . The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol. 2010; 402(3):491-509. PMC: 2978331. DOI: 10.1016/j.jmb.2010.07.051. View

17.

Ozata D, Caramuta S, Velazquez-Fernandez D, Akcakaya P, Xie H, Hoog A . The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer. 2011; 18(6):643-55. PMC: 3201061. DOI: 10.1530/ERC-11-0082. View

18.

Davies H, Bignell G, Cox C, Stephens P, Edkins S, Clegg S . Mutations of the BRAF gene in human cancer. Nature. 2002; 417(6892):949-54. DOI: 10.1038/nature00766. View

19.

Xekouki P, Pacak K, Almeida M, Wassif C, Rustin P, Nesterova M . Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?. J Clin Endocrinol Metab. 2011; 97(3):E357-66. PMC: 3319210. DOI: 10.1210/jc.2011-1179. View

20.

Akiyama S, Olden K, Yamada K . Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev. 1995; 14(3):173-89. DOI: 10.1007/BF00690290. View